文献速递主动脉疾病

腔内与开放腹主动脉瘤修复后感染性主动脉移植物手术移除的结局

Outcomes of Surgical Explantation of Infected Aortic Grafts After Endovascular and Open Abdominal Aneurysm Repair.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2018-08-23

该回顾性研究分析了2008年1月至2016年12月间26例腹主动脉瘤修复后主动脉移植物感染并接受移植物移除及原位重建的患者,其中感染腔内移植物16例、感染常规移植物10例。总体30天死亡率为23.1%,感染腔内移植物组为37.5%,感染常规移植物组为0%(p = .027);感染腔内移植物组术后主要并发症发生率为50%,感染常规移植物组为40%(p = .619)。

要点

  • 感染腔内移植物组30天死亡率为37.5%,感染常规移植物组为0%(p = .027)。
  • 感染腔内移植物组术后主要并发症发生率为50%,感染常规移植物组为40%(p = .619)。
  • 感染腔内移植物组内脏上阻断率为93.8%,感染常规移植物组为20%(p = .001);术后急性肾损伤发生率分别为50%和0%(p = .009)。

核心结论

  • 移植物移除及原位重建被接受为主动脉移植物感染的首选治疗。
  • 然而,感染腔内移植物的再次手术与显著更高的死亡率和并发症率相关。
  • 需要肾上主动脉阻断似乎是感染腔内移植物组结局更差的一个可能解释。

研究设计与样本

  • 回顾性综述了2008年1月至2016年12月间所有腹主动脉瘤修复后发生主动脉移植物感染并接受常规或腔内主动脉移植物移除的患者数据。
  • 所有患者均接受利福平浸泡的合成移植物进行原位重建。
  • 共纳入26例患者,其中感染腔内移植物16例,感染常规移植物10例。
  • 主要终点为30天死亡率;次要终点为术后主要并发症。

主要发现

  • 总体30天死亡率为23.1%,感染腔内移植物组为37.5%,感染常规移植物组为0%(p = .027)。
  • 术后主要并发症在感染腔内移植物组发生8例(50%),在感染常规移植物组发生4例(40%)(p = .619)。
  • 感染腔内移植物组的内脏上阻断率高于感染常规移植物组(93.8% vs. 20%,p = .001)。
  • 感染腔内移植物组术后急性肾损伤发生率高于感染常规移植物组(50% vs. 0%,p = .009)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Infection of the vascular graft represents one of the most threatening complications after aortic repair. It is rare and associated with high morbidity and mortality rates. The aim of this study was to present short-term outcomes after surgical treatment of infected aortic grafts after endovascular and open repair of abdominal aortic aneurysms (AAAs). METHODS: Data of all patients affected by aortic graft infection after aneurysm repair who underwent an explantation of a conventional or endovascular aortic graft between January 2008 and December 2016 were retrospectively reviewed. All patients underwent in situ reconstruction using a rifampicin soaked synthetic graft. The primary endpoint of this study was 30 day mortality; secondary endpoints were major post-operative complications. RESULTS: Twenty-six patients were included in the cohort, 16 with an infected endograft (iEVAR) and 10 patients with an infected conventional graft (iOAR). Thirty-day mortality was 23.1% overall, 37.5% for iEVAR and 0% (p = .027) for iOAR. Post-operative major complications occurred in eight (50%) patients from the iEVAR group and in four (40%) patients from the iOAR group (p = .619). The supravisceral clamping rate was higher in patients with infected iEVAR (93.8 vs. 20%, p = .001), furthermore a greater incidence of post-operative acute kidney injury was observed (50 vs. 0%, p = .009). CONCLUSIONS: Explantation of the graft and in situ reconstruction for aortic graft infection is accepted as the therapy of choice. However, re-operation for iEVAR is related to significantly higher mortality and morbidity rates. The need for suprarenal aortic clamping seems to be a possible explanation for worse outcomes in iEVAR.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Schaefers JF, Donas KP, Panuccio G, et al. Outcomes of Surgical Explantation of Infected Aortic Grafts After Endovascular and Open Abdominal Aneurysm Repair. Eur J Vasc Endovasc Surg. 2018. PMID: 30146325. doi:10.1016/j.ejvs.2018.07.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。